Cite
HARVARD Citation
Huygens, S. et al. (2023). Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant. Clinical infectious diseases. pp. e507-e509. [Online].